Global Microneedle Drug Delivery Systems Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Microneedle Drug Delivery Systems Market is presumed to reach the market size of nearly USD 12.75 Billion by 2032 from USD 6.23 Billion in 2023 with a CAGR of 8.29% under the study period 2024-2032.

Micro Needle Drug Delivery System is a systemic drug delivery device used to administer drugs/vaccines by penetrating the outermost layer of the skin. This system compromises of a microneedle and a drug patch. These microneedles can be dissolvable and degradable. The use of microneedle benefits the health care sectors since it improves the comfort of patients especially those with needle phobia. It also reduces the rate of microbial invasion at the delivery point. Various types of micro needles can be produced depending on the nature of use and the type of material. The only issue associated with these micro needles is that they are very small in size and can remain under the skin due to breakage if not administered with caution. They are very convenient to use that they can enable self administration of medicines as well.

MARKET DYNAMICS

The market of microneedle drug delivery systems is bound to grow at an alarming rate because of its ease of use, growth in research and development initiatives, need for safer alternatives to vaccinate people in large numbers. The need for minimally trained health care professionals to administer, ease of storage, distribution, and disposal can boost the market growth. This system can exhibit few inferior characteristics like drug degradation, irritation on the site of application, poor absorption which can act as restraining factors for market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Microneedle Drug Delivery Systems. The growth and trends of Microneedle Drug Delivery Systems industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Microneedle Drug Delivery Systems market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Solid
Hollow
Dissolving
Coated
Others

By Material

Silicon
Metal
Polymer
Others

By Application

Dermatology
Drug Delivery
Pain Management
Cancer Therapy
Vaccine Delivery
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Microneedle Drug Delivery Systems market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Microneedle Drug Delivery Systems market include Raphas, Novartis International AG, Becton Dickinson And Company, B. Braun, NanoPass Technologies Limited, Termo, Smiths Medical, Cardinal Health, 3M. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11211929

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. MICRONEEDLE DRUG DELIVERY SYSTEMS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Material
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data
5.3. Analysis By Type
5.4. Solid Historic and Forecast Sales By Regions
5.5. Hollow Historic and Forecast Sales By Regions
5.6. Dissolving Historic and Forecast Sales By Regions
5.7. Coated Historic and Forecast Sales By Regions
5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET ANALYSIS BY MATERIAL

6.1. Overview By Material
6.2. Historical and Forecast Data
6.3. Analysis By Material
6.4. Silicon Historic and Forecast Sales By Regions
6.5. Metal Historic and Forecast Sales By Regions
6.6. Polymer Historic and Forecast Sales By Regions
6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET ANALYSIS BY APPLICATION

7.1. Overview By Application
7.2. Historical and Forecast Data
7.3. Analysis By Application
7.4. Dermatology Historic and Forecast Sales By Regions
7.5. Drug Delivery Historic and Forecast Sales By Regions
7.6. Pain Management Historic and Forecast Sales By Regions
7.7. Cancer Therapy Historic and Forecast Sales By Regions
7.8. Vaccine Delivery Historic and Forecast Sales By Regions
7.9. Others Historic and Forecast Sales By Regions

8. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE MICRONEEDLE DRUG DELIVERY SYSTEMS COMPANIES

9.1. Microneedle Drug Delivery Systems Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF MICRONEEDLE DRUG DELIVERY SYSTEMS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Raphas
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Novartis International AG
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Becton Dickinson And Company
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. B. Braun
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. NanoPass Technologies Limited
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Termo
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Smiths Medical
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Cardinal Health
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. 3M
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies